Skip to main content

Evaluation and Management of the Patient with Hypertension

  • Chapter
  • 105 Accesses

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

References and Recommended Reading

  1. Cutler JA, Psaty BM, MacMahon S, et al.: Public health issues in hypertension control: what has been learned from clinical trials. In Hypertension: Pathophysiology, Diagnosis, and Management,2nd edn. Laragh JH, Brenner BM, eds. New York: Raven Press, Ltd.; 1995:253–270.

    Google Scholar 

  2. Burt VL, Cutler JA, Higgins M, et al.: Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population. Hypertension 1995, 26:60–69.

    Google Scholar 

  3. Grimm RJ, Grandits GA, Cutler MA, et al.: Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the treatment of mild hypertension study. Arch Intern Med 1997, 157:638–648.

    Google Scholar 

  4. Millar JA, Lever AF, Burke V: Pulse pressure as a risk factor for cardiovascular events in the MRC mild hypertension trial. J Hypertens 1999, 17: 1065–1072.

    Article  PubMed  CAS  Google Scholar 

  5. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991, 265: 3255–3264.

    Article  Google Scholar 

  6. Task Force on Blood Pressure Control in Children: Report of the second task force on blood pressure control in children-1987. Pediatrics 1987, 79: 1–25.

    Google Scholar 

  7. American Society of Hypertension: Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry. Am JHypertens 1992, 5: 207–209.

    Google Scholar 

  8. Haynes RB, Sackett DL, Taylor DW, et al.: Increased absenteeism from work after detection and labeling of hypertensive patients. NEngIJMed 1978, 299:741–744.

    Google Scholar 

  9. Weiss NA: Relation of high blood pressure to headache, epistaxis, and selected other symptoms. NEngIJMed 1972, 287: 631–633.

    Article  CAS  Google Scholar 

  10. Tso O, Jampol L: Hypertensive retinopathy, choroidopathy, and optic neuropathy of hypertensive ocular disease. In Hypertension.’ Pathophysiology, Diagnosis, and Management, vol. 1. Laragh JH, Brenner BM, eds. New York: Raven Press; 1990: 433–465.

    Google Scholar 

  11. Frolich ED, Chobanian AV, Devereau RB, et al.: The heart in hypertension [review article]. NEngIJMed 1992, 327:998–1008.

    Google Scholar 

  12. Tyrrell JB: Cushing’s syndrome. In Cecil Textbook of Medicine, edn 19. Wyngaarden JB, Smith LH, Bennett JC, eds. Philadelphia: WB Saunders; 1992: 1284–1288.

    Google Scholar 

  13. The Sixth Report of the Joint National Committee on Detection, Evaluation and Diagnosis of High Blood Pressure (JNC VI). Arch Intern Med 1997, 157: 2413–2446.

    Article  Google Scholar 

  14. Rakic V, Burke V, Beilin LJ: Effects of coffee on ambulatory blood pressure in older men and women. Hypertension 1999, 33: 869–873.

    Article  PubMed  CAS  Google Scholar 

  15. Reisin E, Abel R, Modan M, et al.: Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. NEnglJMed 1978, 298:1–6.

    Google Scholar 

  16. Boyer JL, Kasch FW: Exercise therapy in hypertensive men. JAMA 1970, 211: 1667–671.

    Article  Google Scholar 

  17. Appel LJ, Moore TJ, Obarzanek E, et al.: A clinical trial of the effects of dietary patterns on blood pressure. NEnglJMed 1997, 336:1117–1124.

    Google Scholar 

  18. The Trials of Hypertension Prevention Collaborative Research Group: Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. Arch Intern Med 1997, 157 (6): 657–667.

    Article  Google Scholar 

  19. Bennett PH, Haffner S, Kasiske BL, et al.: Screening and management of microalbuminuria in patients with diabetes mellitus. Am JKidney Dis 1995, 107–112.

    Google Scholar 

  20. Pontremoli R: Microalbuminuria in essential hypertension-its relation to cardiovascular risk factors. Nephrol Dial Transplant 1996, 11: 2113–2134.

    Article  PubMed  CAS  Google Scholar 

  21. Mejiia AD, Egan BR, Schork NJ, et al.: Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension. Ann Intern Med 1990, 112:270–277.

    Google Scholar 

  22. Pickering TG, James GD, Boddie C, et al.: How common is white coat hypertension? JAMA 1988, 259:225–228.

    Google Scholar 

  23. Cardillo C, De Felice F, Campia U, et al.: Psychophysiological reactivity and cardiac end-organ changes in white coat hypertension. Hypertension 1993, 21:836–844.

    Google Scholar 

  24. Dickerson JE, Hingorani AD, Ashby MJ, et al.: Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet 1999, 353:2008–2013.

    Google Scholar 

  25. Effects of an angiotensin-converting enzyme inhibitor, ramipril

    Google Scholar 

  26. on cardiovascular events in high-risk patients. NEnglJMed 2000, 342:145–153.1

    Google Scholar 

  27. Willenheimer R, Dahlof F, Rydberg E, et al.: AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions. Eur Heart)1999,20:997–1008.

    Google Scholar 

  28. The ALLHAT officers and coordinators for the ALLHAT

    Google Scholar 

  29. collaborative research group: Major cardiovascular events in hypertensive patients randomized to doxazosin versus chlorthalidone.JAMA 2000, 283: 1967–1975.

    Google Scholar 

  30. Lazarus JM, Bourgiognie JJ, Buckalew VM, et al.: Achievement and safety of a low blood pressure goal in chronic renal failure: the Modification of Diet in Renal Disease Study Group. Hypertension 1997, 29:641–650.

    Google Scholar 

  31. Quyyumi AA: Circadian rhythms in cardiovascular disease. Am Heart J 1990, 130: 726–733.

    Article  Google Scholar 

  32. Alderman MH, Cohen J, Roque R, Madhavan S: Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet 1997, 349: 495–598.

    Article  Google Scholar 

  33. Troyler H: Socioeconomic status, age, and sex in the prevalence and prognosis of hypertension in blacks and whites. In Hypertension Pathophysiology, Diagnosis, and Management, vol. 1. Laraugh JH, Brenner BM, eds. New York: Raven Press; 1990: 159–174.

    Google Scholar 

Select Bibliography

  • Kaplan NM: Clinical Hypertension, edn 7. Collins N, ed. Baltimore: Williams-Wilkins; 1998.

    Google Scholar 

  • Laraugh JH, Brenner BM: Hypertension, edn 2. New York: Raven Press; 1995.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Current Medicine, Inc.

About this chapter

Cite this chapter

Luke, R.G. (2001). Evaluation and Management of the Patient with Hypertension. In: Alpert, J.S. (eds) Cardiology for the primary care Physician. Current Medicine Group. https://doi.org/10.1007/978-1-4615-6601-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-6601-4_15

  • Publisher Name: Current Medicine Group

  • Print ISBN: 978-1-4615-6603-8

  • Online ISBN: 978-1-4615-6601-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics